-
Mashup Score: 0Newly passed House bill could close orphan drug loophole that evergreens exclusivity - 4 year(s) ago
The Orphan Drug Act of 1983 was intended to reward biopharma companies for developing drugs for rare diseases. But over the years, criticism has increased over unexpected misuse of the law. Now, a new bill has made the first step toward closing one of the loopholes by requiring some applicants to prove that they don’t expect to recoup R&D costs.
Source: FiercePharmaCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2World Orphan Drug Congress 2020 | 2 - 5 November 2020 - 4 year(s) ago
Europe’s largest commercially-focused event for the rare disease industry
Source: World Orphan Drug Congress 2020Categories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 0World Orphan Drug Congress 2020 | 2 - 5 November 2020 - 4 year(s) ago
Europe’s largest commercially-focused event for the rare disease industry
Source: World Orphan Drug Congress 2020Categories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 4Trends In Orphan Drug Spending And Out-Of-Pocket Spending Among US Children, 2013–18 | Health Affairs - 4 year(s) ago
Research Article Health Affairs Vol.39 No.10 Trends In Orphan Drug Spending And Out-Of-Pocket Spending Among US Children, 2013–18
Source: www.healthaffairs.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 1World Orphan Drug Congress 2020 | 2 - 5 November 2020 - 4 year(s) ago
Europe’s largest commercially-focused event for the rare disease industry
Source: World Orphan Drug Congress 2020Categories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 0
Catalyst Pharmaceuticals alleged the FDA “arbitrarily and capriciously” approved a rival drug by applying different approval standards.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Remdesivir Designation as Orphan Drug Exposed Policy Loophole - 4 year(s) ago
The short-lived designation of remdesivir as an Orphan Drug to treat COVID-19 exposed loophole in the Orphan Drug Act.
Source: ContagionLiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Remdesivir Designation as Orphan Drug Exposed Policy Loophole - 4 year(s) ago
The short-lived designation of remdesivir as an Orphan Drug to treat COVID-19 exposed loophole in the Orphan Drug Act.
Source: ContagionLiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0
The global orphan drug conference and expo where orphan drug stakeholders gather to talk about strategies to expedite orphan drug development.
Categories: Latest Headlines, Rare DiseaseTweet-
Join NORD at the 2020 World Orphan Drug Congress USA from August 24-26! The World #OrphanDrug Congress is a global gathering of 1,500 attendees from 50 countries, w/ 350+ speakers & 260+ sessions covering all aspects of rare drug development & research. https://t.co/b1IN41C5cc https://t.co/SWtKDvz0c7
-
-
Mashup Score: 0GoodRx: These are the most expensive drugs in the U.S. - 4 year(s) ago
GoodRx has released its latest list of the most expensive drugs in America, with orphan drugs and therapies for rare conditions continuing to top the ranking.
Source: FierceHealthcareCategories: Healthcare Professionals, Latest HeadlinesTweet
Newly passed House bill could close #orphandrug loophole that evergreens exclusivity https://t.co/KG8y9uTcGE